Importance of polymorphic variants of Tumour Necrosis Factor - α gene in the etiology of Intrauterine Growth Restriction

Ginekologia Polska

Volumn 89, Issue 3, 2018, Pages 160-168

  Kaluba Skotarczak, Agnieszka ^a   Magiełda, Justyna ^a   Romała, Anna ^a   Kurzawińska, Grazyna ^a   Barlik, Magdalena ^a   Drews, Krzysztof ^a   Ozarowski, Marcin ^a,b   Łozinski, Tomasz ^c   Seremak Mrozikiewicz, Agnieszka ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF NATURAL FIBRES AND MEDICINAL PLANTS   (Poland)

^c Provincial Specialist Hospital in Rzeszow   (Poland)

Author keywords

Genetic polymorphism; Intrauterine growth restriction (IUGR); Pregnancy; Tumor necrosis factor alpha (TNF )

Indexed keywords

TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; ALLELE; GENETICS; HETEROZYGOTE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; ALLELES; FETAL GROWTH RETARDATION; HETEROZYGOTE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 85045438189     PISSN: 00170011     EISSN: 25436767     Source Type: Journal    
DOI: 10.5603/GP.a2018.0027     Document Type: Article

References (17)

1. Resnik R. Intrauterine growth restriction. Obstet Gynecol. 2002; 99(3): 490-496, doi: 10.1097/00006250-200203000-00020, indexed in Pubmed: 11864679
2. Campbell LR, Pang Yi, Ojeda NB, et al. Intracerebral lipopolysaccharide induces neuroinflammatory change and augmented brain injury in growth-restricted neonatal rats. Pediatr Res. 2012; 71(6): 645-652, doi: 10.1038/pr.2012.26, indexed in Pubmed: 22337231
3. Mandruzzato G, Antsaklis A, Botet F, et al. WAPM. Intrauterine restriction (IUGR). J Perinat Med. 2008; 36(4): 277-281, doi: 10.1515/JPM.2008.050, indexed in Pubmed: 18598115
4. Ropacka-Lesiak M, Breborowicz G. [Management of pregnancy complicated by intrauterine fetal growth restriction]. Ginekol Pol. 2012; 83(5): 373-376, indexed in Pubmed: 22708336
5. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet. 1999; 353(9166): 1789-1792, doi: 10.1016/S0140-6736(98)07546-1, indexed in Pubmed: 10348008
6. Hunt JS, Chen HL, Miller L. Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod. 1996; 54(3): 554-562, doi: 10.1095/biolreprod54.3.554, indexed in Pubmed: 8835376
7. Haider S, Knöfler M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta. 2009; 30(2): 111-123, doi: 10.1016/j.placenta.2008.10.012, indexed in Pubmed: 19027157
8. Giannubilo SR, Tranquilli AL. Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia. Curr Med Chem. 2012; 19(27): 4562-4571, doi: 10.2174/092986712803306466, indexed in Pubmed: 22876895
9. Kilani RT, Mackova M, Davidge ST, et al. Endogenous tumor necrosis factor alpha mediates enhanced apoptosis of cultured villous trophoblasts from intrauterine growth-restricted placentae. Reproduction. 2007; 133(1): 257-264, doi: 10.1530/REP-06-0080, indexed in Pubmed: 17244751
10. Nedwin GE, Naylor SL, Sakaguchi AY, et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res. 1985; 13(17): 6361-6373, doi: 10.1093/nar/13.17.6361, indexed in Pubmed: 2995927
11. Takashiba S, Shapira L, Amar S, et al. Cloning and characterization of human TNF alpha promoter region. Gene. 1993; 131(2): 307-308, doi: 10.1016/0378-1119(93)90314-s, indexed in Pubmed: 8406029
12. Amu S, Hahn-Zoric M, Malik A, et al. Cytokines in the placenta of Pakistani newborns with and without intrauterine growth retardation. Pediatr Res. 2006; 59(2): 254-258, doi: 10.1203/01.pdr.0000196332.37565.7d, indexed in Pubmed: 16439588
13. Molvarec A, Jermendy A, Nagy B, et al. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction. Clin Chim Acta. 2008; 392(1-2): 52-57, doi: 10.1016/j.cca.2008.03.009, indexed in Pubmed: 18396154
14. Kaiser T, Grehan M, Brennecke SP, et al. Association of the TNF2 allele with eclampsia. Gynecol Obstet Invest. 2004; 57(4): 204-209, doi: 10.1159/000076689, indexed in Pubmed: 14963369
15. Saarela T, Hiltunen M, Helisalmi S, et al. Tumour necrosis factor-alpha gene haplotype is associated with pre-eclampsia. Mol Hum Reprod. 2005; 11(6): 437-440, doi: 10.1093/molehr/gah182, indexed in Pubmed: 15901845
16. Laddha NC, Dwivedi M, Begum R. Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo. PLoS One. 2012; 7(12): e52298, doi: 10.1371/journal.pone.0052298, indexed in Pubmed: 23284977
17. Palmirotta R, La Farina F, Ferroni P, et al. TNFA gene promoter polymorphisms and susceptibility to recurrent pregnancy loss in Italian women. Reprod Sci. 2010; 17(7): 659-666, doi: 10.1177/1933719110366603, indexed in Pubmed: 20388617